Reilly Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $238K | Buy |
3,820
+1,224
| +47% | +$71.8K | 0.02% | 192 |
|
|
2021
Q3 | $154K | Sell |
2,596
-321
| -11% | -$21.1K | 0.01% | 219 |
|
|
2021
Q2 | $195K | Buy |
2,917
+441
| +18% | +$28.8K | 0.02% | 209 |
|
|
2021
Q1 | $156K | Buy |
2,476
+1
| +0% | +$62 | 0.01% | 223 |
|
|
2020
Q4 | $154K | Buy |
2,475
+51
| +2% | +$3.14K | 0.01% | 212 |
|
|
2020
Q3 | $146K | Sell |
2,424
-350
| -13% | -$21.1K | 0.02% | 201 |
|
|
2020
Q2 | $163K | Sell |
2,774
-39
| -1% | -$2.33K | 0.02% | 187 |
|
|
2020
Q1 | $157K | Sell |
2,813
-222
| -7% | -$13.6K | 0.02% | 183 |
|
|
2019
Q4 | $195K | Buy |
3,035
+1,051
| +53% | +$60.2K | 0.02% | 187 |
|
|
2019
Q3 | $101K | Hold |
1,984
| – | – | 0.01% | 249 |
|
|
2019
Q2 | $90K | Sell |
1,984
-306
| -13% | -$14.3K | 0.01% | 262 |
|
|
2019
Q1 | $109K | Sell |
2,290
-208
| -8% | -$10.4K | 0.01% | 226 |
|
|
2018
Q4 | $130K | Buy |
2,498
+961
| +63% | +$51.6K | 0.02% | 206 |
|
|
2018
Q3 | $95K | Sell |
1,537
-650
| -30% | -$38.6K | 0.01% | 250 |
|
|
2018
Q2 | $121K | Buy |
2,187
+75
| +4% | +$4.05K | 0.02% | 199 |
|
|
2018
Q1 | $134K | Sell |
2,112
-318
| -13% | -$20.5K | 0.02% | 187 |
|
|
2017
Q4 | $149K | Sell |
2,430
-502
| -17% | -$31.4K | 0.02% | 187 |
|
|
2017
Q3 | $187K | Sell |
2,932
-510
| -15% | -$29.8K | 0.03% | 157 |
|
|
2017
Q2 | $192K | Sell |
3,442
-680
| -16% | -$37K | 0.03% | 155 |
|
|
2017
Q1 | $224K | Buy |
4,122
+175
| +4% | +$9.6K | 0.04% | 144 |
|
|
2016
Q4 | $231K | Sell |
3,947
-15,786
| -80% | -$863K | 0.04% | 139 |
|
|
2016
Q3 | $1.06M | Buy |
19,733
+2,140
| +12% | +$137K | 0.19% | 72 |
|
|
2016
Q2 | $1.29M | Buy |
17,593
+1,606
| +10% | +$113K | 0.24% | 62 |
|
|
2016
Q1 | $1.02M | Buy |
15,987
+298
| +2% | +$18.8K | 0.17% | 75 |
|
|
2015
Q4 | $1.08M | Sell |
15,689
-2,280
| -13% | -$151K | 0.19% | 68 |
|
|
2015
Q3 | $1.06M | Buy |
17,969
+2,960
| +20% | +$188K | 0.19% | 77 |
|
|
2015
Q2 | $999K | Buy |
15,009
+1,503
| +11% | +$99K | 0.17% | 76 |
|
|
2015
Q1 | $871K | Buy |
13,506
+4,145
| +44% | +$259K | 0.15% | 79 |
|
|
2014
Q4 | $553K | Buy |
9,361
+8,305
| +786% | +$468K | 0.13% | 72 |
|
|
2014
Q3 | $54K | Buy |
1,056
+302
| +40% | +$15.1K | 0.01% | 244 |
|
|
2014
Q2 | $36K | Sell |
754
-230
| -23% | -$11.3K | 0.01% | 311 |
|
|
2014
Q1 | $51K | Sell |
984
-2,927
| -75% | -$156K | 0.01% | 271 |
|
|
2013
Q4 | $208K | Buy |
3,911
+361
| +10% | +$18.4K | 0.05% | 105 |
|
|
2013
Q3 | $167K | Sell |
3,550
-157
| -4% | -$6.89K | 0.05% | 112 |
|
|
2013
Q2 | $163K | Buy |
+3,707
| New | +$161K | 0.05% | 111 |
|
Other funds holding BMY
Reilly Financial Advisors's BMY Position: Q4 2021 in Review
Reilly Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 47% in Q4 2021, buying an estimated $71.8K and bringing the position to 3,820 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #192.
Reilly Financial Advisors first reported a position in BMY in Q2 2013 and has held it in 35 quarters since. The position peaked at $1.29M in Q2 2016. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Reilly Financial Advisors held 3,820 shares of Bristol-Myers Squibb worth $238K as of Q4 2021.
- Reilly Financial Advisors bought 1,224 Bristol-Myers Squibb shares in Q4 2021, an estimated $71.8K.
- Bristol-Myers Squibb made up 0.02% of Reilly Financial Advisors's portfolio in Q4 2021, its #192 holding.
- Reilly Financial Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 35 quarters since.
- Reilly Financial Advisors's Bristol-Myers Squibb position peaked at $1.29M in Q2 2016.
- 2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.